Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04239209 · ClinicalTrials.gov registry record · NA
Effect of Intensivist Communication on Surrogate Prognosis Interpretation
A NA study of Critical Illness, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
- 1
- Study location
NCT04239209: Completed NA study of Critical Illness, sponsored by Johns Hopkins University.
NCT04239209 is a NA study of Critical Illness that has completed, run by Johns Hopkins University. The registered enrollment target is 302 participants, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04239209, a NA study of Critical Illness, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effect of physician communication styles on the interpretation of prognosis by family members of chronically-ill patients. Participants were randomized to view one of four videos how depicting different physicians disclose prognosis when physicians expect an ICU patient to die.
Primary Outcome
Participant response to the question "If you had to guess, what do you think the doctor thinks is the chance that your loved one will survive this hospitalization?" answered on a 0-100% percentage scale. 0% signifies no chance of survival and 100% signifies definitely will survive.
Conditions Studied
Interventions
- BEHAVIORAL Indirect - other patients
- BEHAVIORAL Indirect - physiology
- BEHAVIORAL Redirection
- BEHAVIORAL Direct communication
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2019-09-27 |
| Est. Completion | 2019-10-17 |
| Phase | NA |
What the finished NCT04239209 record still lists
NCT04239209 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 4 interventions - of which Indirect - other patients is the first listed.
NCT04239209 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04239209 about?
NCT04239209 is a clinical study titled "Effect of Intensivist Communication on Surrogate Prognosis Interpretation". This study evaluates the effect of physician communication styles on the interpretation of prognosis by family members of chronically-ill patients. Participants were randomized to view one of four videos how depicting different physicians disclose prognosis when physicians expect an ICU patient to d...
What is the current status of trial NCT04239209?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2019-09-27. Estimated completion is 2019-10-17.
What conditions does trial NCT04239209 study?
This clinical trial studies the following conditions: Critical Illness.
What interventions are being tested in trial NCT04239209?
The interventions under investigation include: Indirect - other patients (BEHAVIORAL), Indirect - physiology (BEHAVIORAL), Redirection (BEHAVIORAL), Direct communication (BEHAVIORAL).
Who is sponsoring clinical trial NCT04239209?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04239209 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04239209's enrollment target sits among peer trials
302 39th of 91 higher than 53 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI